Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
190.5 USD | -0.85% | -6.46% | -26.37% |
02:57pm | BMO Capital Adjusts Price Target on Biogen to $260 From $285, Outperform Rating Kept | MT |
01:28pm | Oppenheimer Adjusts Biogen Price Target to $270 From $290 | MT |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.